ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs MXN
20.6314
0.00%
Brent Oil
76.495
0.00%
Bitcoin
97,963.20
-0.25%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE

  6. Leclanche Sa (0QP6) Cotización

Leclanche Sa

Leclanche Sa (0QP6)

LSE
1.98
0.00
(0.00%)
Cerrado 05 Enero 10:30AM
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
1.98
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
4,174
0.00 Rango del Día 0.00
1.98 Rango de 52 semanas 1.98
Capitalización de Mercado [m]
1.161B
Precio Anterior
1.98
Precio de Apertura
-
Hora
62
@
0.22
(O)
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
19,987
Acciones en circulación
586,115,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-9.11
Beneficio por acción (BPA)
-0.12
turnover
18.72M
Beneficio neto
-67.53M

Acerca de Leclanche Sa

Sector
Primary Batteries, Dry & Wet
Industria
Primary Batteries, Dry & Wet
Sitio web
www.leclanche.eu
Sede
Yverdon-les-bains, Che
Fundado
-
Leclanche Sa is listed in the Primary Batteries, Dry & Wet sector of the London Stock Exchange with ticker 0QP6. The last closing price for Leclanche was CHF1.98. Over the last year, Leclanche shares have traded in a share price range of CHF 1.98 to CHF 1.98.

Leclanche currently has 586,115,000 shares in issue. The market capitalisation of Leclanche is CHF1.16 billion. Leclanche has a price to earnings ratio (PE ratio) of -9.11.

0QP6 Últimas noticias

Más noticias

Leclanché selected to provide 10 MWh advanced battery system for Scandlines' "PR24" zero-emission freight ferry

Leclanché selected to provide 10 MWh advanced battery system for Scandlines' "PR24" zero-emission freight ferry PR Newswire YVERDON-LES-BAINS, Switzerland and COPENHAGEN, Denmark, April...

05 Abril 2022
PR Newswire (US)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1001.981.981.987541.98DE
4001.981.981.9813271.98DE
12001.981.981.98199871.98DE
26001.981.981.9892911.98DE
52001.981.981.9853011.98DE
156001.981.981.9833431.98DE
260001.981.981.9841901.98DE

0QP6 - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Leclanche?
El precio actual de las acciones de Leclanche es CHF 1.98
¿Cuántas acciones de Leclanche están en circulación?
Leclanche tiene 586,115,000 acciones en circulación
¿Cuál es la capitalización de mercado de Leclanche?
La capitalización de mercado de Leclanche es CHF 1.16B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Leclanche?
Leclanche ha negociado en un rango de CHF 1.98 a CHF 1.98 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Leclanche?
El ratio precio/beneficio de Leclanche es -9.11
¿Cuál es el ratio de efectivo a ventas de Leclanche?
El ratio de efectivo a ventas de Leclanche es 32.92
¿Cuál es la moneda de reporte de Leclanche?
Leclanche presenta sus resultados financieros en CHF
¿Cuál es el último ingresos anual de Leclanche?
El último ingresos anual de Leclanche es CHF 18.72M
¿Cuál es el último beneficio anual de Leclanche?
El último beneficio anual de Leclanche es CHF -67.53M
¿Cuál es la dirección registrada de Leclanche?
La dirección registrada de Leclanche es AVENUE DES SPORTS 42, YVERDON-LES-BAINS, 1400
¿Cuál es la dirección del sitio web de Leclanche?
La dirección del sitio web de Leclanche es www.leclanche.eu
¿En qué sector industrial opera Leclanche?
Leclanche opera en el sector PRIMARY BATTERIES, DRY & WET

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discusión

Ver feed completo
Mr. Bill Mr. Bill 11 minutos hace
https://www.goodrx.com/well-being/sleep/how-to-sleep-with-sciatica
nowwhat2 nowwhat2 13 minutos hace
Could still just be climbing in sympathy w overall crypto mkt

Scathingly poor outlooks

https://www.youtube.com/watch?v=EOsjnOUAw14



https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg

WONDF
DonVance DonVance 14 minutos hace
This will hit 1k this year I believe now.
MSTR
georgejjl georgejjl 15 minutos hace
How many of the 7 million Alzheimer’s patients in the USA are projected to be treated with the MAB infusions during 2025???

How many people with Alzheimer’s in the USA are projected to be treated with donepezil (Aricept) or memantine during 2025???

The treatment used t
AVXL
Mr. Bill Mr. Bill 16 minutos hace
Stretches https://www.healthline.com/health/back-pain/sciatic-stretches#sitting-spinal-stretch
Graniteguy Graniteguy 17 minutos hace
Doc and Investor posters here tend to be negatively biased which you whole heartedly champion, especially "Doc" who's medical opinion is at best questionable, and incredibly biased, to fit a narrative of constant failure for Anavex's Blarcamesine. The fact that you pile onto their "steaming pile of
AVXL
BDEZ BDEZ 19 minutos hace
The Russes hit the jackpot?
BDEZ BDEZ 20 minutos hace
40% of homicides in the US take place in districts with a Soros-funded prosecutor.

Biden gave him a Medal Of Freedom.

https://x.com/EndWokeness/status/1875725808071012529
BDEZ BDEZ 20 minutos hace
Not good, thanks for sharing.
sand sand 27 minutos hace
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 28 minutos hace
Moving hard soon 
EFSH
mining101 mining101 29 minutos hace
Superb
MEGL
benz280c benz280c 36 minutos hace
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 43 minutos hace
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 44 minutos hace
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 47 minutos hace
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 52 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 53 minutos hace
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD
sunspotter sunspotter 58 minutos hace
Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
Investor2014 Investor2014 1 hora hace
The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
AVXL
nowwhat2 nowwhat2 1 hora hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
sunspotter sunspotter 1 hora hace
I rather think you missed the point. It’s not that higher doses of GALT’s drug are toxic, it’s that they are ineffective.

Given the purported mechanism, that almost certainly means lower doses are too, and that the implication that the lower dose worked is merely an artefact.
GALT
nowwhat2 nowwhat2 1 hora hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
XRPUSD

Su Consulta Reciente

LSE
0QP6
Leclanche
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados